ClinicalTrials.gg
RecruitingNCT07178509Updated Jan 7, 2026

A Study of SCAD Using Stress Contrast Echocardiography

An observational study in Spontaneous Coronary Artery Dissection, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Mayo Clinic · Observational

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States — 8 open to participants now, 9 under way, none of them phase 3. Coronary Artery Dissection, Spontaneous · United States.

Planned enrollment
10th of 10
50 · median 675
Started
2025
the only one that year
Observational
10 of 13
6 open now
Registered
10th of 13
by date
Lead sponsor
8 of 13
Mayo Clinic

Among the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, this one is the 10th largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2025, is one of 10 observational ones, and was the 10th registered.

Coronary Artery Dissection, Spontaneous

28 studies on the registry are indexed under Coronary Artery Dissection, Spontaneous; 18 are open to participants now.

Browse Coronary Artery Dissection, Spontaneous studies →

Open to participants now

8 of the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 13 Coronary Artery Dissection, Spontaneous studies recruiting now, 11 (85%) set no upper age limit and 1 (8%) stops at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, or all of them as a file.
02

Study summary

This study aims to fill knowledge gaps regarding microvascular perfusion and pressor response to stress among patients with history of spontaneous coronary artery dissection (SCAD) using stress contrast echocardiography.

03

Conditions studied

  • Spontaneous Coronary Artery Dissection
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients will be recruited from the clinic and community.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult >18 years old
  • Patient has a history of spontaneous coronary artery dissection (SCAD) OR patient is healthy with no significant medical history

Exclusion criteria

Exclusion Criteria:

  • Unable to give consent
  • Allergic or have a history of adverse reaction to dobutamine, the Definity® ultrasound enhancing agent, or atropine.
  • Has a known or suspected to perflutren and therefore cannot be given Definity®.
  • Pregnant.
  • Unable to interrupt breastfeeding.
  • Within 3 months of a heart attack.
  • Severe aortic stenosis.
  • Severe, uncontrolled hypertension (>200/110 mmHg at baseline).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Spontaneous coronary artery dissection (SCAD)

    Subject has a history of spontaneous coronary artery dissection (SCAD)

    Procedure: Stress Echocardiography with Contrast

  • Healthy Subjects

    Subjects are healthy with no significant medical history

    Procedure: Stress Echocardiography with Contrast

Interventions

  • ProcedureStress Echocardiography with Contrast

    Stress Echocardiography with Contrast will be used to assess heart function and blood flow response to stressors.

06

What researchers measure

Primary outcomes

  1. Change in Microvascular Function

    Microvascular Function will be determined by Microvascular Blood Flow (Liters/Minute). Microvascular Blood Flow will be measured by a stress echocardiogram with contrast. A higher Microvascular Blood Flow indicated better blood flow circulation.

    Time frame: Baseline, immediately after the Stress Echocardiography

  2. Change in Blood Pressure

    Change is blood pressure will be measured by a stress echocardiogram with contrast (mmHg).

    Time frame: Baseline, immediately after the Stress Echocardiography

  3. Change in Heart Rate

    Change in heart rate will be measured by a stress echocardiogram with contrast (beats per minute).

    Time frame: Baseline, immediately after the Stress Echocardiography

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2025 (actual). Primary completion is estimated for Sep 2027, 22 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2025
First posted
Sep 17, 2025
StartActual
Nov 25, 2025
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Jan 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07178509
Lead sponsor
Mayo Clinic
Responsible party
Marysia Tweet (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Sep 17, 2025
Start date
Nov 25, 2025
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Jan 7, 2026

Study contacts

Pamela Engrav
Contact
engrav.pamela@mayo.edu
507-255-6938
Marysia Tweet, M.D., M.S.
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion